From: Policy responses to COVID-19: lessons for the global trade and investment regime
Country (in order of nominal GDP per capita) (1) | GDP 2020a (international $) | Total # of interventions enacted (2) | # of health sector interventions (as % of total) (3) | # of health sector subsidies (as % of health sector measures) (4) | # of health sector trade measures (5) | # of health sector investment measures (6) | # of health sector public procurement measures (7) | # of health sector IP measures (8) |
---|---|---|---|---|---|---|---|---|
USA | 59,920 | 476 | 70 (14.7%) | 49 (70%) | 19 (27%) | 1 (1%) | 1 (1%) | 0 |
Germany | 51,451 | 263 | 28 (10.3%) | 15 (54%) | 9 (32%) | 3 (11%) | 0 | 1 (4%) |
France | 42,321 | 161 | 39 (23.8%) | 26 (67%) | 8 (21%) | 4 (10%) | 0 | 1 (3%) |
China | 16,316 | 32 | 7 (21.9%) | 2 (29%) | 5 (71%) | 0 | 0 | 0 |
South Africa | 12,666 | 33 | 5 (15.2%) | 3 (60%) | 2 (40%) | 0 | 0 | 0 |
India | 6,166 | 170 | 56 (32.9%) | 17 (30%) | 32 (57%) | 3 (5%) | 4 (7%) | 0 |